View Older Stories

Feb 11, 2026 11:00AM Alvotech issues 12.5 million shares to subsidiary for $65 million

Feb 5, 2026 05:48AM Alvotech reports positive results for Entyvio biosimilar study

Feb 2, 2026 04:42AM Alvotech signs biosimilar supply deals with Sandoz for Canada, Australia

Jan 29, 2026 04:50AM Alvotech settles global patent disputes for Eylea biosimilar

Jan 6, 2026 07:16AM Alvotech names Lisa Graver as CEO, Wessman to remain executive chairman

Dec 31, 2025 04:30PM Alvotech secures $100 million term loan facility

Dec 22, 2025 05:39AM Alvotech launches first biosimilar to Simponi in Europe via Advanz Pharma

Dec 19, 2025 05:13AM Alvotech and Teva reach settlement for Eylea biosimilar launch in Q4 2026

Dec 17, 2025 08:39AM Alvotech issues $108 million convertible bonds, reaffirms 2025 guidance

Nov 24, 2025 05:31AM Alvotech receives European approval for denosumab biosimilar AVT03

Nov 20, 2025 04:00AM Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz

Nov 12, 2025 06:02PM Alvotech (ALVO) Tops Q3 EPS by 50c

Nov 10, 2025 04:02AM Alvotech wins UK court ruling for Eylea biosimilar manufacturing

Nov 6, 2025 09:00AM Alvotech and Advanz Pharma get UK approval for golimumab biosimilar

Nov 4, 2025 04:49AM Deutsche Bank Downgrades Alvotech SA (ALVO) to Hold

Nov 3, 2025 03:52AM FDA issues complete response letter for Alvotech AVT05 biosimilar application

Oct 14, 2025 03:26AM Morgan Stanley Upgrades Alvotech SA (ALVO) to Overweight

Oct 6, 2025 04:55AM EMA accepts biosimilar application for Alvotech's omalizumab drug

Sep 23, 2025 03:58AM Deutsche Bank Upgrades Alvotech SA (ALVO) to Buy

Sep 22, 2025 06:18AM European regulator recommends Alvotech's denosumab biosimilar

Sep 22, 2025 05:11AM EMA recommends approval of ALVO's Gobivaz biosimilar to Simponi

Sep 19, 2025 07:46AM Alvotech receives Japan approval for three biosimilars

Aug 20, 2025 06:06AM Alvotech hires Patrik Ling as VP of investor relations Scandinavia

Aug 13, 2025 04:31PM Alvotech (ALVO) Reports 1H EPS of $0.50

Aug 13, 2025 04:31PM Alvotech (ALVO) Reports 1H EPS of $0.50

Jul 10, 2025 06:08AM Alvotech names Linda Jónsdóttir as new CFO

Jun 25, 2025 04:15AM Alvotech (ALVO) Announces Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair

Jun 23, 2025 05:14AM Alvotech (ALVO) Announces EMA Recommended Market Approval of AVT06

Jun 11, 2025 04:19PM Alvotech's (ALVO) Private Placement Completed with Delivery of SDRs and Shares to Investors

Jun 5, 2025 08:58AM Dr. Reddy's (RDY) stock rises on biosimilar collaboration with Alvotech (ALVO)

May 21, 2025 07:22AM Key Takeaways from Virtual Generics & Biosimilars Day at UBS

May 7, 2025 04:58PM Alvotech (ALVO) Tops Q1 EPS by 32c

May 5, 2025 07:03AM Alvotech (ALVO) and Teva (TEVA) Announce FDA Approval of Interchangeability for SELARSDI with Stelara

Mar 20, 2025 11:43AM Northland Reiterates Outperform Rating on Alvotech SA (ALVO)

Mar 18, 2025 08:32AM Alvotech (ALVO) and Dr. Reddy’s Announce FDA acceptance of BLA for AVT03, a Proposed Biosimilar to Prolia and Xgeva

Feb 21, 2025 06:26AM Alvotech (ALVO) and Teva (TEVA) Announce SELARSDI Injection Now Available in the U.S.

Feb 14, 2025 11:10AM UBS Reiterates Buy Rating on Alvotech SA (ALVO)

Feb 12, 2025 03:40AM Alvotech SA (ALVO) PT Raised to $14 at Morgan Stanley

Jan 27, 2025 06:02AM Alvotech (ALVO) and Teva (TEVA) Announce Filing Acceptance of U.S. Biologics License Applications for AVT05

Nov 4, 2024 07:03AM Alvotech (ALVO): EMA Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi

Oct 22, 2024 07:07AM Alvotech (ALVO) and Teva (TEVA) Announce U.S. FDA Approval of Additional Presentation of SELARSDI, Expanding its Label

Sep 25, 2024 06:16AM Alvotech (ALVO) Initiates Confirmatory Patient Study for AVT16

Aug 16, 2024 05:12AM Citi Reiterates Neutral Rating on Alvotech SA (ALVO)

Aug 15, 2024 04:30PM Alvotech (ALVO) Misses Q2 EPS by 59c

Aug 15, 2024 06:15AM Alvotech (ALVO) Announces EMA Acceptance of Marketing Application for AVT06

Jul 22, 2024 06:31AM Alvotech (ALVO) and STADA launch Uzpruvo

Jul 2, 2024 01:02PM Deutsche Bank Reiterates Hold Rating on Alvotech SA (ALVO), 'we continue to monitor ongoing Simlandi RX trends in the US'

Jul 2, 2024 09:07AM Alvotech (ALVO) Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva

Jul 1, 2024 05:46AM Alvotech (ALVO) Reports Prelim Q2 Results

Jun 26, 2024 05:26AM Alvotech (ALVO) Receives Conversion Notices for Majority of Convertible Bonds

View Older Stories